Jenburkt Pharmaceuticals Ltd — Updates, 21-05-2025: Company Update

Jenburkt Pharmaceuticals Limited has announced a board meeting to approve the financial results for the quarter and half-year. The standalone audited financial results for the quarter and financial year ended March 31 have been published and are accessible on the company’s and stock exchange websites. This update affirms the company’s commitment to transparency and keeps investors informed on its recent financial performance, aiding in monitoring operational health and business progress.